Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computational design and modeling of nanobodies toward SARS‐CoV‐2 receptor binding domain
Jingyi Yang, Zhao Zhang, Fengyuan Yang, et al.
Chemical Biology & Drug Design (2021) Vol. 98, Iss. 1, pp. 1-18
Open Access | Times Cited: 52

Showing 26-50 of 52 citing articles:

Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering
Gennady M. Verkhivker
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2928-2928
Open Access | Times Cited: 16
SARS-CoV-2: Prediction of critical ionic amino acid mutations
Atlal El-Assaad, Tayssir Hamieh
Computers in Biology and Medicine (2024) Vol. 178, pp. 108688-108688
Open Access | Times Cited: 3
Advancements in nanobody generation: Integrating conventional, in silico, and machine learning approaches
D. Jagadeeswara Reddy, Girijasankar Guntuku, Mary Sulakshana Palla
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 11, pp. 3375-3388
Open Access | Times Cited: 3
Insights into the structural peculiarities of the N-terminal and receptor binding domains of the spike protein from the SARS-CoV-2 Omicron variant
Fatemeh Bayani, Negin Safaei Hashkavaei, Vladimir N. Uversky, et al.
Computers in Biology and Medicine (2022) Vol. 147, pp. 105735-105735
Open Access | Times Cited: 14
Quercetin attenuates viral infections by interacting with target proteins and linked genes in chemicobiological models
Md. Atiar Rahman, Fauzia Mahanaz Shorobi, Md. Nazim Uddin, et al.
In Silico Pharmacology (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 14
Computational design of novel nanobodies targeting the receptor binding domain of variants of concern of SARS-CoV-2
Phoomintara Longsompurana, Thanyada Rungrotmongkol, Nongluk Plongthongkum, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0293263-e0293263
Open Access | Times Cited: 8
Molecular Mechanism-Driven Discovery of Novel Small Molecule Inhibitors against Drug-Resistant SARS-CoV-2 Mpro Variants
Jingyi Yang, Beibei Fu, Rongpei Gou, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 20, pp. 7998-8009
Closed Access | Times Cited: 2
Allosteric Determinants of the SARS-CoV-2 Spike Protein Binding with Nanobodies: Examining Mechanisms of Mutational Escape and Sensitivity of the Omicron Variant
Gennady M. Verkhivker
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2172-2172
Open Access | Times Cited: 10
Atomic Mechanisms of Transthyretin Tetramer Dissociation Studied by Molecular Dynamics Simulations
Shuangyan Zhou, Huizhen Zou, Yu Wang, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 24, pp. 6667-6678
Closed Access | Times Cited: 10
De novo design and Rosetta‐based assessment of high‐affinity antibody variable regions (Fv) against the SARS‐CoV‐2 spike receptor binding domain (RBD)
Veda Sheersh Boorla, Ratul Chowdhury, R. Ramasubramanian, et al.
Proteins Structure Function and Bioinformatics (2022) Vol. 91, Iss. 2, pp. 196-208
Open Access | Times Cited: 10
Applications of nanobodies in the prevention, detection, and treatment of the evolving SARS-CoV-2
Wenyi Wang, Yue Hu, Bohan Li, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115401-115401
Open Access | Times Cited: 10
Structural basis of Omicron immune evasion: A comparative computational study
Darshan Contractor, Christoph Globisch, Shiv Swaroop, et al.
Computers in Biology and Medicine (2022) Vol. 147, pp. 105758-105758
Open Access | Times Cited: 9
From De Novo Design to Redesign: Harnessing Computational Protein Design for Understanding SARS-CoV-2 Molecular Mechanisms and Developing Therapeutics
Aditya K. Padhi, Parismita Kalita, Shweata Maurya, et al.
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 41, pp. 8717-8735
Closed Access | Times Cited: 5
Virus structure and structure-based antivirals
Zlatka Plavec, Ina Pöhner, Antti Poso, et al.
Current Opinion in Virology (2021) Vol. 51, pp. 16-24
Open Access | Times Cited: 12
Computational Saturation Mutagenesis of SARS-CoV-1 Spike Glycoprotein: Stability, Binding Affinity, and Comparison With SARS-CoV-2
Adebiyi Sobitan, Vidhyanand Mahase, Raina Rhoades, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 11
Computational Protein Design - Where it goes?
Binbin Xu, Yingjun Chen, Weiwei Xue
Current Medicinal Chemistry (2023) Vol. 31, Iss. 20, pp. 2841-2854
Closed Access | Times Cited: 4
Targeting Spike Protein: Modified Antibody for Broad-Spectrum Binding to Coronaviruses: An In Silico Study
Rai RC
Virology & Immunology Journal (2023) Vol. 7, Iss. 3, pp. 1-15
Open Access | Times Cited: 4
Nanobody Engineering: Computational Modelling and Design for Biomedical and Therapeutic Applications
Nehad El Salamouni, Jordan H. Cater, Lisanne Spenkelink, et al.
(2024)
Open Access | Times Cited: 1
Enhancing affinity of neutralizing SARS-CoV-2 nanobody through facile structure-guided mutations in CDRs
Vishakha Singh, Mandar Bhutkar, Shweta Choudhary, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Investigating the structure-activity relationship of marine polycyclic batzelladine alkaloids as promising inhibitors for SARS-CoV-2 main protease (Mpro)
Alaa M. Elgohary, Abdo A. Elfiky, Florbela Pereira, et al.
Computers in Biology and Medicine (2022) Vol. 147, pp. 105738-105738
Open Access | Times Cited: 7
In silico and immunoinformatics based multiepitope subunit vaccine design for protection against visceral leishmaniasis
Deep Bhowmik, A Bhuyan, Seshan Gunalan, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9731-9752
Closed Access | Times Cited: 3
Multi-structural molecular docking (MOD) combined with molecular dynamics reveal the structural requirements of designing broad-spectrum inhibitors of SARS-CoV-2 entry to host cells
Anqi Da, Meritxell Wu‐Lu, Jovan Dragelj, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Exploring the Binding Mechanism of NRG1–ERBB3 Complex and Discovery of Potent Natural Products to Reduce Diabetes-Assisted Breast Cancer Progression
Sulaiman K. Marafie, Eman Alshawaf, Mohamed Abu‐Farha, et al.
Interdisciplinary Sciences Computational Life Sciences (2023) Vol. 15, Iss. 3, pp. 452-464
Open Access | Times Cited: 2
In silico analysis of a novel protein in CAR T- cell therapy for the treatment of hematologic cancer through molecular modelling, docking, and dynamics approach
Rimjhim Mohanty, Manoswini Manoswini, Ajit Kumar Dhal, et al.
Computers in Biology and Medicine (2022) Vol. 151, pp. 106285-106285
Closed Access | Times Cited: 3
Machine learning and molecular modeling based design of nanobodies targeting human serotonin transporter and receptor
Binbin Xu, Jin Liu, Weiwei Xue
Advances in protein chemistry and structural biology (2024)
Closed Access

Scroll to top